Clinical Trials Browser

NIH × Bortezomib × Gynecologic × Clear all

NCT00023712 2019-07-30

Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Phase 2 Completed

58 enrolled 14 charts

Carcinoma, Ovarian Epithelial

NCT00028912 2011-04-26

Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Phase 1 Completed

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms